Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers

ESWT Treatment of Diabetic Foot VS. Standard Care Trial

The purpose of this study is to determine if Extra-corporeal-shockwave Therapy (ESWT) added to standard of care wound therapy significantly improves time to complete wound healing in diabetic foot wounds.

Inclusion Criteria:

1. Signed Informed Consent.
2. Diagnosed with Diabetes.
3. An Active Diabetic Ulcer larger than 5 cm2
4. Sufficient limb perfusion.(e.g no compartment syndrome ankle Brachial Index (ABI)>=0.5

Exclusion Criteria:

1. Pregnancy.

2. The patient is under another research protocol.

3. One of the following:

   A. ABI<0.5 C.Significant Arterial-Venous injury. D. Lymphedema.

4. The patient underwent Chemotherapy or Radiotherapy 60 days or less prior to recruitment date.

5. Sufficient Noncompliant.

6. Sickle Cell Anemia, HIV, Immunodeficiency, HgB Anemia, DVT, Chronic Renal Failure, Systemic use of Steroids